-
1
-
-
77951625637
-
Epidemiological profile of meningococcal disease in the United States
-
Harrison L. Epidemiological profile of meningococcal disease in the United States. Clin Infect Dis. 2010;50(suppl 2):S37-S44.
-
(2010)
Clin Infect Dis
, vol.50
, Issue.SUPPL. 2
-
-
Harrison, L.1
-
2
-
-
77952004260
-
Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: Effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity
-
Campbell H, Andrews N, Borrow R, et al. Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity. Clin Vaccine Immunol. 2010;17:840-847.
-
(2010)
Clin Vaccine Immunol
, vol.17
, pp. 840-847
-
-
Campbell, H.1
Andrews, N.2
Borrow, R.3
-
3
-
-
40549089883
-
Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity
-
DOI 10.1086/527401
-
Maiden M, Ibarz-Parvon A, Urwin R, et al. Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. J Infect Dis. 2008;197:737-743. (Pubitemid 351364476)
-
(2008)
Journal of Infectious Diseases
, vol.197
, Issue.5
, pp. 737-743
-
-
Maiden, M.C.J.1
Ibarz-Pavon, A.B.2
Urwin, R.3
Gray, S.J.4
Andrews, N.J.5
Clarke, S.C.6
Walker, A.M.7
Evans, M.R.8
Kroll, J.S.9
Neal, K.R.10
Ala'Aldeen, D.A.A.11
Crook, D.W.12
Cann, K.13
Harrison, S.14
Cunningham, R.15
Baxter, D.16
Kaczmarski, E.17
MacLennan, J.18
Cameron, J.C.19
Stuart, J.M.20
more..
-
4
-
-
3242768475
-
Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction
-
DOI 10.1016/S0140-6736(04)16725-1, PII S0140673604167251
-
Trotter CL, Andrews NJ, Kaczmarski EB, et al. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet. 2004;364:365-367. (Pubitemid 38970013)
-
(2004)
Lancet
, vol.364
, Issue.9431
, pp. 365-367
-
-
Trotter, C.L.1
Andrews, N.J.2
Kaczmarski, E.B.3
Miller, E.4
Ramsay, M.E.5
-
5
-
-
74549171099
-
Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and Haemophilus influenzae Type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine
-
Borrow R, Andrews N, Findlow H, et al. Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and Haemophilus influenzae Type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine. Clin Vaccine Immunol. 2010;17:154-159.
-
(2010)
Clin Vaccine Immunol
, vol.17
, pp. 154-159
-
-
Borrow, R.1
Andrews, N.2
Findlow, H.3
-
6
-
-
79951681571
-
Persistence of immunity following a booster dose of a Haemophilus influenzae type B-meningococcal serogroup C glycoconjugate vaccine: Follow-up of a randomized controlled trial
-
Khatami A, Snape MD, John T, et al. Persistence of immunity following a booster dose of a Haemophilus influenzae type B-meningococcal serogroup C glycoconjugate vaccine: follow-up of a randomized controlled trial. Pediatr Infect Dis J. 2011;30:197-202.
-
(2011)
Pediatr Infect Dis J
, vol.30
, pp. 197-202
-
-
Khatami, A.1
Snape, M.D.2
John, T.3
-
7
-
-
77952993552
-
Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primaryschool children in 1999-2000 and response to a booster: A phase 4 clinical trial
-
Perrett K, Winter A, Kibwana E, et al. Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primaryschool children in 1999-2000 and response to a booster: a phase 4 clinical trial. Clin Infect Dis. 2010;50:1601-1610.
-
(2010)
Clin Infect Dis
, vol.50
, pp. 1601-1610
-
-
Perrett, K.1
Winter, A.2
Kibwana, E.3
-
8
-
-
55849138735
-
Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era
-
Trotter C, Borrow R, Findlow J, et al. Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era. Clin Vaccine Immunol. 2008;15:1694-1698.
-
(2008)
Clin Vaccine Immunol
, vol.15
, pp. 1694-1698
-
-
Trotter, C.1
Borrow, R.2
Findlow, J.3
-
9
-
-
61349145533
-
Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines
-
Pollard A, Perrett K, Beverley P. Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines. Nat Rev Immunol. 2009;9:213-220.
-
(2009)
Nat Rev Immunol
, vol.9
, pp. 213-220
-
-
Pollard, A.1
Perrett, K.2
Beverley, P.3
-
10
-
-
33751555760
-
Serogroup C meningococcal glycoconjugate vaccine in adolescents: Persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization
-
DOI 10.1086/508776
-
Snape MD, Kelly DF, Salt P, et al. Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization. Clin Infect Dis. 2006;43:1387-1394. (Pubitemid 44845637)
-
(2006)
Clinical Infectious Diseases
, vol.43
, Issue.11
, pp. 1387-1394
-
-
Snape, M.D.1
Kelly, D.F.2
Salt, P.3
Green, S.4
Snowden, C.5
Diggle, L.6
Borkowski, A.7
Yu, L.-M.8
Moxon, E.R.9
Pollard, A.J.10
-
11
-
-
67649491062
-
Investigation of serum bactericidal activity in childhood and adolescence 3-6 years after vaccination with a single dose of serogroup C meningococcal conjugate vaccine
-
Sakou I-I, Tzanakaki G, Tsolia M, et al. Investigation of serum bactericidal activity in childhood and adolescence 3-6 years after vaccination with a single dose of serogroup C meningococcal conjugate vaccine. Vaccine. 2009;27:4408-4411.
-
(2009)
Vaccine
, vol.27
, pp. 4408-4411
-
-
Sakou, I.-I.1
Tzanakaki, G.2
Tsolia, M.3
-
12
-
-
33644884439
-
Antibody persistence 3 years after immunization of adolescents with quadrivalent meningococcal conjugate vaccine
-
Vu D, Welsch J, Zuno-Mitchell P, et al. Antibody persistence 3 years after immunization of adolescents with quadrivalent meningococcal conjugate vaccine. J Infect Dis. 2006;193:821-828.
-
(2006)
J Infect Dis
, vol.193
, pp. 821-828
-
-
Vu, D.1
Welsch, J.2
Zuno-Mitchell, P.3
-
13
-
-
33750629955
-
CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells
-
Kelly D, Snape M, Clutterbuck E, et al. CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells. Blood. 2006;108:2642-2647.
-
(2006)
Blood
, vol.108
, pp. 2642-2647
-
-
Kelly, D.1
Snape, M.2
Clutterbuck, E.3
-
14
-
-
47149093375
-
Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: Observational study
-
DOI 10.1136/bmj.39563.545255.AE
-
Snape MD, Kelly DF, Lewis S, et al. Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study. Br Med J. 2008;336:1487-1491. (Pubitemid 351977021)
-
(2008)
BMJ
, vol.336
, Issue.7659
, pp. 1487-1491
-
-
Snape, M.D.1
Kelly, D.F.2
Lewis, S.3
Banner, C.4
Kibwana, L.5
Moore, C.E.6
Diggle, L.7
John, T.8
Yu, L.M.9
Borrow, R.10
Borkowski, A.11
Nau, C.12
Pollard, A.J.13
-
15
-
-
0342891343
-
Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays
-
Maslanka S, Gheesling L, Libutti D, et al. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. Clin Diagn Lab Immunol. 1997;4:156-167. (Pubitemid 27130227)
-
(1997)
Clinical and Diagnostic Laboratory Immunology
, vol.4
, Issue.2
, pp. 156-167
-
-
Maslanka, S.E.1
Gheesling, L.L.2
Libutti, D.E.3
Donaldson, K.B.J.4
Harakeh, H.S.5
Dykes, J.K.6
Arhin, F.F.7
Devi, S.J.N.8
Frasch, C.E.9
Huang, J.C.10
Kriz-Kuzemenska, P.11
Lemmon, R.D.12
Lorange, M.13
Peeters, C.C.A.M.14
Quataert, S.15
Tai, J.Y.16
Carlone, G.M.17
Mills, E.L.18
Ashton, F.E.19
Diepevaen, J.20
Bielecki, J.21
Bybel, M.22
Cloutier, M.23
Poolman, J.T.24
more..
-
16
-
-
67349179167
-
Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease
-
Frasch C, Borrow R, Donnelly J. Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease. Vaccine. 2009; 27(suppl 2):B112-B116.
-
(2009)
Vaccine
, vol.27
, Issue.SUPPL. 2
-
-
Frasch, C.1
Borrow, R.2
Donnelly, J.3
-
17
-
-
0028305189
-
Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay
-
Gheesling L, Carlone G, Pais L, et al. Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardised enzyme-linked immunosorbent assay. J Clin Microbiol. 1994;32:1475-1482. (Pubitemid 24179378)
-
(1994)
Journal of Clinical Microbiology
, vol.32
, Issue.6
, pp. 1475-1482
-
-
Gheesling, L.L.1
Carlone, G.M.2
Pais, L.B.3
Holder, P.F.4
Maslanka, S.E.5
Plikaytis, B.D.6
Achtman, M.7
Densen, P.8
Frasch, C.E.9
Kayhty, H.10
Mays, J.P.11
Nencioni, L.12
Peeters, C.13
Phipps, D.C.14
Poolman, J.T.15
Rosenqvist, E.16
Siber, G.R.17
Thiesen, B.18
Tai, J.19
-
18
-
-
34548719417
-
Reconsideration of the use of meningococcal polysaccharide vaccine
-
DOI 10.1097/INF.0b013e3180cc2c25, PII 0000645420070800000011
-
Granoff D, Pollard A. Reconsideration of the use of meningococcal polysaccharide vaccine. Pediatr Infect Dis J. 2007;26:716-722. (Pubitemid 47424642)
-
(2007)
Pediatric Infectious Disease Journal
, vol.26
, Issue.8
, pp. 716-722
-
-
Granoff, D.M.1
Pollard, A.J.2
-
19
-
-
33745271338
-
Modeling future changes to the meningococcal serogroup C conjugate (MCC) vaccine program in England and Wales
-
Trotter C, Edmunds W, Ramsay M, et al. Modeling future changes to the meningococcal serogroup C conjugate (MCC) vaccine program in England and Wales. Hum Vaccin. 2006;2:68-73. (Pubitemid 43927160)
-
(2006)
Human Vaccines
, vol.2
, Issue.2
, pp. 68-73
-
-
Trotter, C.L.1
Edmunds, W.J.2
Ramsay, M.E.3
Miller, E.4
-
20
-
-
49749096045
-
Meningococcal C booster not recommended by evidence
-
Thomas H, Andrews N, Trotter C, et al. Meningococcal C booster not recommended by evidence. Br Med J. 2008;337:a1139.
-
(2008)
Br Med J
, vol.337
-
-
Thomas, H.1
Andrews, N.2
Trotter, C.3
-
21
-
-
79951871167
-
Adolescent immunisation: The next big thing?
-
Finn A, Clarke E, Mytton J. Adolescent immunisation: the next big thing? Arch Dis Child. 2011;96:497-499.
-
(2011)
Arch Dis Child
, vol.96
, pp. 497-499
-
-
Finn, A.1
Clarke, E.2
Mytton, J.3
-
22
-
-
79954624170
-
Immunisation of adolescents in the UK
-
Kale AR, Snape MD. Immunisation of adolescents in the UK. Arch Dis Child. 2011;96:492-495.
-
(2011)
Arch Dis Child
, vol.96
, pp. 492-495
-
-
Kale, A.R.1
Snape, M.D.2
-
23
-
-
65349110862
-
Update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations: An advisory committee statement
-
Immunization NACo
-
Immunization NACo. Update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations: an advisory committee statement. Can Commun Dis Rep. 2009; 35(ACS-3):1-40.
-
(2009)
Can Commun Dis Rep
, vol.35
, Issue.ACS-3
, pp. 1-40
-
-
-
24
-
-
34250819829
-
Vaccinating adolescents against meningococcal disease in Canada: A cost-effectiveness analysis
-
DOI 10.1016/j.vaccine.2007.04.071, PII S0264410X07004781
-
De Wals P, Coudeville L, Trottier P, et al. Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis. Vaccine. 2007;25:5433-5440. (Pubitemid 46977525)
-
(2007)
Vaccine
, vol.25
, Issue.29
, pp. 5433-5440
-
-
De Wals, P.1
Coudeville, L.2
Trottier, P.3
Chevat, C.4
Erickson, L.J.5
Nguyen, V.H.6
-
25
-
-
79251607440
-
Updated recommendations for use of meningococcal conjugate vaccines-Advisory Committee on Immunization Practices (ACIP), 2010
-
Centers for Disease Control and Prevention
-
Centers for Disease Control and Prevention. Updated recommendations for use of meningococcal conjugate vaccines-Advisory Committee on Immunization Practices (ACIP), 2010. Morbid Mortal Wkly Rep. 2011:72-76.
-
(2011)
Morbid Mortal Wkly Rep.
, pp. 72-76
-
-
|